Questions about data manipulation [GxP / QC / QA]

posted by qualityassurance – 2024-04-30 13:38 (433 d 05:42 ago) – Posting: # 23967
Views: 10,866

Dear Forum members,

❝ Dr. Anders Fuglsang has developed several software programs to detect such manipulation.


Is it advisable that CRO use this software (after implementing the SOP within the system) and prove that no such manipulation was done during BE study. By this way both sponsors and CROs are relaxed and regulatory authority will also have readily available data from the software.
The idea behind above approach is, there is no other way of finding such manipulation (profile duplication) during routine QA review or monitoring by sponsor.

Regards,
QA

Complete thread:

UA Flag
Activity
 Admin contact
23,428 posts in 4,929 threads, 1,682 registered users;
91 visitors (0 registered, 91 guests [including 11 identified bots]).
Forum time: 19:20 CEST (Europe/Vienna)

No matter what side of the argument you are on,
you always find people on your side
that you wish were on the other.    Thomas Berger

The Bioequivalence and Bioavailability Forum is hosted by
BEBAC Ing. Helmut Schütz
HTML5